ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
-2.06%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$268M
AUM Growth
-$59.5M
(-18%)
Cap. Flow
-$51.2M
Cap. Flow
% of AUM
-19.11%
Top 10 Holdings %
Top 10 Hldgs %
44.52%
Holding
92
New
17
Increased
19
Reduced
32
Closed
23
Top Buys
| 1 |
Universal Health Services
UHS
|
$9.88M |
| 2 |
Abbott
ABT
|
$7.99M |
| 3 |
Johnson & Johnson
JNJ
|
$6.83M |
| 4 |
Becton Dickinson
BDX
|
$6.28M |
| 5 |
Elevance Health
ELV
|
$4.74M |
Top Sells
| 1 |
Danaher
DHR
|
$9.04M |
| 2 |
McKesson
MCK
|
$8.53M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$7.85M |
| 4 |
VanEck Biotech ETF
BBH
|
$6.22M |
| 5 |
Sabra Healthcare REIT
SBRA
|
$6.16M |
Sector Composition
| 1 | Healthcare | 93.35% |
| 2 | Real Estate | 1.88% |
| 3 | Financials | 1.53% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ocular Therapeutix
OCUL
$2.37B
| $1.16M | 0.43% |
+178,461
| New | +$1.16M |
|
52
Icon
ICLR
$13.6B
| $992K | 0.37% |
+8,400
| New | +$992K |
|
|
BLCM
53
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $947K | 0.35% |
+14,430
| New | +$947K |
|
|
NVRO
54
DELISTED
NEVRO CORP.
NVRO
| $927K | 0.35% |
10,701
-16,260
| -60% | -$1.41M |
|
55
Teleflex
TFX
$5.78B
| $918K | 0.34% |
+3,600
| New | +$918K |
|
56
Jazz Pharmaceuticals
JAZZ
$7.86B
| $770K | 0.29% |
5,100
+150
| +3% | +$22.6K |
|
57
Regeneron Pharmaceuticals
REGN
$60.8B
| $758K | 0.28% |
2,200
-3,400
| -61% | -$1.17M |
|
|
RDUS
58
DELISTED
Radius Health, Inc.
RDUS
| $686K | 0.26% |
19,100
-22,300
| -54% | -$801K |
|
59
Dentsply Sirona
XRAY
$2.92B
| $664K | 0.25% |
+13,200
| New | +$664K |
|
60
Qiagen
QGEN
$10.3B
| $662K | 0.25% |
+19,333
| New | +$662K |
|
|
ZGNX
61
DELISTED
Zogenix, Inc.
ZGNX
| $653K | 0.24% |
16,300
-3,700
| -19% | -$148K |
|
|
RNTX
62
Rein Therapeutics, Inc. Common Stock
RNTX
$31M
| $615K | 0.23% |
3,785
-515
| -12% | -$83.7K |
|
|
MDCO
63
DELISTED
Medicines Co
MDCO
| $560K | 0.21% |
17,000
-24,200
| -59% | -$797K |
|
64
Viking Therapeutics
VKTX
$3.03B
| $520K | 0.19% |
+119,100
| New | +$520K |
|
|
RETA
65
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $513K | 0.19% |
+25,000
| New | +$513K |
|
|
AVDL
66
Avadel Pharmaceuticals
AVDL
$1.53B
| $406K | 0.15% |
+55,700
| New | +$406K |
|
|
AKTX
67
Akari Therapeutics
AKTX
$26.7M
| $359K | 0.13% |
9,875
-180
| -2% | -$6.54K |
|
68
AnaptysBio
ANAB
$613M
| $326K | 0.12% |
3,130
-6,570
| -68% | -$684K |
|
69
Assembly Biosciences
ASMB
$183M
| – | – |
-792
| Closed | -$430K |
|
70
Ascendis Pharma
ASND
$12.5B
| – | – |
-37,828
| Closed | -$1.52M |
|
71
Apellis Pharmaceuticals
APLS
$3.55B
| – | – |
-17,600
| Closed | -$382K |
|
|
72
VanEck Biotech ETF
BBH
$356M
| – | – |
-49,899
| Closed | -$6.22M |
|
73
Biogen
BIIB
$20.6B
| – | – |
-15,399
| Closed | -$4.91M |
|
74
BioMarin Pharmaceuticals
BMRN
$11.1B
| – | – |
-10,100
| Closed | -$901K |
|
75
Cencora
COR
$56.7B
| – | – |
-55,240
| Closed | -$5.07M |
|